(Q42661912)

4 November 2017

title

Long-term efficacy of rasagiline in early Parkinson's disease (English)

1 reference

4 November 2017

1 reference

1 reference

2

Robert A Hauser

1 reference

4 November 2017

5

Joanne Wojcieszek

1 reference

4 November 2017

1

Mark F Lew

1 reference

4 November 2017

Howard I Hurtig

3

1 reference

4 November 2017

William G Ondo

series ordinal

4

1 reference

4 November 2017

Tamar Goren

series ordinal

6

1 reference

4 November 2017

Cheryl J Fitzer-Attas

series ordinal

7

1 reference

4 November 2017

publication date

1 June 2010

1 reference

International Journal of Neuroscience

4 November 2017

published in

1 reference

4 November 2017

volume

120

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

404-408

1 reference

Treatment should not be initiated too soon in Parkinson's disease

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Compulsive eating and weight gain related to dopamine agonist use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Timing of treatment initiation in Parkinson's disease: a need for reappraisal?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Association of dopamine agonist use with impulse control disorders in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207451003778744

10.3109/00207451003778744

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference